Titan Pharmaceuticals Inc (TTNP)
7.210
-0.17
(-2.30%)
USD |
NASDAQ |
Mar 28, 16:00
7.14
-0.07
(-0.97%)
Pre-Market: 20:00
Titan Pharmaceuticals Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2022 | 0.061M |
September 30, 2022 | 0.014M |
June 30, 2022 | 0.05M |
March 31, 2022 | 0.492M |
December 31, 2021 | 1.171M |
September 30, 2021 | 2.612M |
June 30, 2021 | 3.59M |
March 31, 2021 | 4.394M |
December 31, 2020 | 4.838M |
September 30, 2020 | 3.604M |
June 30, 2020 | 3.533M |
March 31, 2020 | 2.786M |
December 31, 2019 | 2.605M |
September 30, 2019 | 3.631M |
June 30, 2019 | 4.334M |
March 31, 2019 | 6.50M |
December 31, 2018 | 6.619M |
September 30, 2018 | 5.44M |
June 30, 2018 | 3.83M |
March 31, 2018 | 1.239M |
December 31, 2017 | 0.215M |
September 30, 2017 | 0.192M |
June 30, 2017 | 0.178M |
March 31, 2017 | 15.10M |
December 31, 2016 |
Date | Value |
---|---|
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | 3.494M |
March 31, 2015 | 3.645M |
December 31, 2014 | 3.645M |
September 30, 2014 | 3.644M |
June 30, 2014 | 4.931M |
March 31, 2014 | 6.218M |
December 31, 2013 | 10.48M |
September 30, 2013 | 12.83M |
June 30, 2013 | 11.86M |
March 31, 2013 | 11.02M |
December 31, 2012 | 7.117M |
September 30, 2012 | 5.271M |
June 30, 2012 | 5.055M |
March 31, 2012 | 4.39M |
December 31, 2011 | 4.068M |
September 30, 2011 | 5.381M |
June 30, 2011 | 7.969M |
March 31, 2011 | 8.616M |
December 31, 2010 | 10.09M |
September 30, 2010 | 7.394M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.014M
Minimum
Sep 2022
6.50M
Maximum
Mar 2019
2.763M
Average
3.160M
Median
Revenue (TTM) Benchmarks
Cutera Inc | 230.18M |
AIM ImmunoTech Inc | 0.193M |
Perspective Therapeutics Inc | 6.956M |
Protalix BioTherapeutics Inc | 65.49M |
Armata Pharmaceuticals Inc | -- |